DuPont Analysis: Disaggregation of ROE, ROA, and Net Profit MarginQuarterly Data
Annual Data
Quarterly Data
Decomposing ROE involves expressing net income divided by shareholders’ equity as the product of component ratios.
Eli Lilly & Co. (NYSE:LLY), DuPont Analysis (Q)
Johnson & Johnson (NYSE:JNJ), DuPont Analysis (Q)
AbbVie Inc. (NYSE:ABBV), DuPont Analysis (Q)
Merck & Co. Inc. (NYSE:MRK), DuPont Analysis (Q)
Thermo Fisher Scientific Inc. (NYSE:TMO), DuPont Analysis (Q)
Danaher Corp. (NYSE:DHR), DuPont Analysis (Q)
Amgen Inc. (NASDAQ:AMGN), DuPont Analysis (Q)
Pfizer Inc. (NYSE:PFE), DuPont Analysis (Q)
Bristol-Myers Squibb Co. (NYSE:BMY), DuPont Analysis (Q)
Gilead Sciences Inc. (NASDAQ:GILD), DuPont Analysis (Q)
Vertex Pharmaceuticals Inc. (NASDAQ:VRTX), DuPont Analysis (Q)
Regeneron Pharmaceuticals Inc. (NASDAQ:REGN), DuPont Analysis (Q)
Two-Component Disaggregation of ROE
Annual Data
Quarterly Data
Celgene Corp., decomposition of ROE (quarterly data)
ROE
=
ROA
×
Financial Leverage
Sep 30, 2019
48.65%
=
14.22%
×
3.42
Jun 30, 2019
52.44%
=
13.45%
×
3.90
Mar 31, 2019
58.11%
=
12.61%
×
4.61
Dec 31, 2018
65.67%
=
11.40%
×
5.76
Sep 30, 2018
59.51%
=
8.45%
×
7.04
Jun 30, 2018
81.57%
=
8.37%
×
9.75
Mar 31, 2018
55.18%
=
8.26%
×
6.68
Dec 31, 2017
42.48%
=
9.75%
×
4.36
Sep 30, 2017
35.02%
=
10.87%
×
3.22
Jun 30, 2017
31.18%
=
8.69%
×
3.59
Mar 31, 2017
27.87%
=
7.39%
×
3.77
Dec 31, 2016
30.29%
=
7.12%
×
4.26
Sep 30, 2016
37.72%
=
7.97%
×
4.73
Jun 30, 2016
34.71%
=
7.25%
×
4.79
Mar 31, 2016
33.18%
=
6.49%
×
5.12
Dec 31, 2015
27.07%
=
5.92%
×
4.57
Sep 30, 2015
30.79%
=
6.05%
×
5.09
Jun 30, 2015
34.76%
=
12.38%
×
2.81
Mar 31, 2015
36.06%
=
13.95%
×
2.58
Dec 31, 2014
30.65%
=
11.53%
×
2.66
Sep 30, 2014
—
=
—
×
2.84
Jun 30, 2014
—
=
—
×
3.22
Mar 31, 2014
—
=
—
×
2.83
Based on:
10-Q (reporting date: 2019-09-30) ,
10-Q (reporting date: 2019-06-30) ,
10-Q (reporting date: 2019-03-31) ,
10-K (reporting date: 2018-12-31) ,
10-Q (reporting date: 2018-09-30) ,
10-Q (reporting date: 2018-06-30) ,
10-Q (reporting date: 2018-03-31) ,
10-K (reporting date: 2017-12-31) ,
10-Q (reporting date: 2017-09-30) ,
10-Q (reporting date: 2017-06-30) ,
10-Q (reporting date: 2017-03-31) ,
10-K (reporting date: 2016-12-31) ,
10-Q (reporting date: 2016-09-30) ,
10-Q (reporting date: 2016-06-30) ,
10-Q (reporting date: 2016-03-31) ,
10-K (reporting date: 2015-12-31) ,
10-Q (reporting date: 2015-09-30) ,
10-Q (reporting date: 2015-06-30) ,
10-Q (reporting date: 2015-03-31) ,
10-K (reporting date: 2014-12-31) ,
10-Q (reporting date: 2014-09-30) ,
10-Q (reporting date: 2014-06-30) ,
10-Q (reporting date: 2014-03-31) .
The primary reason for the decrease in return on equity ratio (ROE) over Q3 2019 is the decrease in financial leverage ratio.
Three-Component Disaggregation of ROE
Annual Data
Quarterly Data
Celgene Corp., decomposition of ROE (quarterly data)
ROE
=
Net Profit Margin
×
Asset Turnover
×
Financial Leverage
Sep 30, 2019
48.65%
=
34.64%
×
0.41
×
3.42
Jun 30, 2019
52.44%
=
32.24%
×
0.42
×
3.90
Mar 31, 2019
58.11%
=
30.11%
×
0.42
×
4.61
Dec 31, 2018
65.67%
=
26.51%
×
0.43
×
5.76
Sep 30, 2018
59.51%
=
19.66%
×
0.43
×
7.04
Jun 30, 2018
81.57%
=
19.84%
×
0.42
×
9.75
Mar 31, 2018
55.18%
=
21.06%
×
0.39
×
6.68
Dec 31, 2017
42.48%
=
22.66%
×
0.43
×
4.36
Sep 30, 2017
35.02%
=
27.66%
×
0.39
×
3.22
Jun 30, 2017
31.18%
=
21.66%
×
0.40
×
3.59
Mar 31, 2017
27.87%
=
18.30%
×
0.40
×
3.77
Dec 31, 2016
30.29%
=
17.87%
×
0.40
×
4.26
Sep 30, 2016
37.72%
=
19.83%
×
0.40
×
4.73
Jun 30, 2016
34.71%
=
19.08%
×
0.38
×
4.79
Mar 31, 2016
33.18%
=
17.54%
×
0.37
×
5.12
Dec 31, 2015
27.07%
=
17.49%
×
0.34
×
4.57
Sep 30, 2015
30.79%
=
19.07%
×
0.32
×
5.09
Jun 30, 2015
34.76%
=
26.41%
×
0.47
×
2.81
Mar 31, 2015
36.06%
=
30.83%
×
0.45
×
2.58
Dec 31, 2014
30.65%
=
26.44%
×
0.44
×
2.66
Sep 30, 2014
—
=
—
×
—
×
2.84
Jun 30, 2014
—
=
—
×
—
×
3.22
Mar 31, 2014
—
=
—
×
—
×
2.83
Based on:
10-Q (reporting date: 2019-09-30) ,
10-Q (reporting date: 2019-06-30) ,
10-Q (reporting date: 2019-03-31) ,
10-K (reporting date: 2018-12-31) ,
10-Q (reporting date: 2018-09-30) ,
10-Q (reporting date: 2018-06-30) ,
10-Q (reporting date: 2018-03-31) ,
10-K (reporting date: 2017-12-31) ,
10-Q (reporting date: 2017-09-30) ,
10-Q (reporting date: 2017-06-30) ,
10-Q (reporting date: 2017-03-31) ,
10-K (reporting date: 2016-12-31) ,
10-Q (reporting date: 2016-09-30) ,
10-Q (reporting date: 2016-06-30) ,
10-Q (reporting date: 2016-03-31) ,
10-K (reporting date: 2015-12-31) ,
10-Q (reporting date: 2015-09-30) ,
10-Q (reporting date: 2015-06-30) ,
10-Q (reporting date: 2015-03-31) ,
10-K (reporting date: 2014-12-31) ,
10-Q (reporting date: 2014-09-30) ,
10-Q (reporting date: 2014-06-30) ,
10-Q (reporting date: 2014-03-31) .
The primary reason for the decrease in return on equity ratio (ROE) over Q3 2019 is the decrease in financial leverage ratio.
Five-Component Disaggregation of ROE
Annual Data
Quarterly Data
Celgene Corp., decomposition of ROE (quarterly data)
ROE
=
Tax Burden
×
Interest Burden
×
EBIT Margin
×
Asset Turnover
×
Financial Leverage
Sep 30, 2019
48.65%
=
0.88
×
0.90
×
43.78%
×
0.41
×
3.42
Jun 30, 2019
52.44%
=
0.86
×
0.89
×
42.19%
×
0.42
×
3.90
Mar 31, 2019
58.11%
=
0.84
×
0.88
×
40.51%
×
0.42
×
4.61
Dec 31, 2018
65.67%
=
0.84
×
0.87
×
36.51%
×
0.43
×
5.76
Sep 30, 2018
59.51%
=
0.60
×
0.87
×
37.66%
×
0.43
×
7.04
Jun 30, 2018
81.57%
=
0.63
×
0.88
×
36.07%
×
0.42
×
9.75
Mar 31, 2018
55.18%
=
0.66
×
0.89
×
36.09%
×
0.39
×
6.68
Dec 31, 2017
42.48%
=
0.68
×
0.89
×
37.28%
×
0.43
×
4.36
Sep 30, 2017
35.02%
=
0.94
×
0.88
×
33.59%
×
0.39
×
3.22
Jun 30, 2017
31.18%
=
0.89
×
0.85
×
28.43%
×
0.40
×
3.59
Mar 31, 2017
27.87%
=
0.86
×
0.83
×
25.51%
×
0.40
×
3.77
Dec 31, 2016
30.29%
=
0.84
×
0.83
×
25.68%
×
0.40
×
4.26
Sep 30, 2016
37.72%
=
0.81
×
0.84
×
29.00%
×
0.40
×
4.73
Jun 30, 2016
34.71%
=
0.82
×
0.84
×
27.75%
×
0.38
×
4.79
Mar 31, 2016
33.18%
=
0.79
×
0.85
×
26.05%
×
0.37
×
5.12
Dec 31, 2015
27.07%
=
0.79
×
0.87
×
25.48%
×
0.34
×
4.57
Sep 30, 2015
30.79%
=
0.83
×
0.89
×
25.66%
×
0.32
×
5.09
Jun 30, 2015
34.76%
=
0.85
×
0.93
×
33.52%
×
0.47
×
2.81
Mar 31, 2015
36.06%
=
0.86
×
0.94
×
38.15%
×
0.45
×
2.58
Dec 31, 2014
30.65%
=
0.86
×
0.93
×
33.10%
×
0.44
×
2.66
Sep 30, 2014
—
=
—
×
—
×
—
×
—
×
2.84
Jun 30, 2014
—
=
—
×
—
×
—
×
—
×
3.22
Mar 31, 2014
—
=
—
×
—
×
—
×
—
×
2.83
Based on:
10-Q (reporting date: 2019-09-30) ,
10-Q (reporting date: 2019-06-30) ,
10-Q (reporting date: 2019-03-31) ,
10-K (reporting date: 2018-12-31) ,
10-Q (reporting date: 2018-09-30) ,
10-Q (reporting date: 2018-06-30) ,
10-Q (reporting date: 2018-03-31) ,
10-K (reporting date: 2017-12-31) ,
10-Q (reporting date: 2017-09-30) ,
10-Q (reporting date: 2017-06-30) ,
10-Q (reporting date: 2017-03-31) ,
10-K (reporting date: 2016-12-31) ,
10-Q (reporting date: 2016-09-30) ,
10-Q (reporting date: 2016-06-30) ,
10-Q (reporting date: 2016-03-31) ,
10-K (reporting date: 2015-12-31) ,
10-Q (reporting date: 2015-09-30) ,
10-Q (reporting date: 2015-06-30) ,
10-Q (reporting date: 2015-03-31) ,
10-K (reporting date: 2014-12-31) ,
10-Q (reporting date: 2014-09-30) ,
10-Q (reporting date: 2014-06-30) ,
10-Q (reporting date: 2014-03-31) .
The primary reason for the decrease in return on equity ratio (ROE) over Q3 2019 is the decrease in financial leverage ratio.
Two-Component Disaggregation of ROA
Annual Data
Quarterly Data
Celgene Corp., decomposition of ROA (quarterly data)
ROA
=
Net Profit Margin
×
Asset Turnover
Sep 30, 2019
14.22%
=
34.64%
×
0.41
Jun 30, 2019
13.45%
=
32.24%
×
0.42
Mar 31, 2019
12.61%
=
30.11%
×
0.42
Dec 31, 2018
11.40%
=
26.51%
×
0.43
Sep 30, 2018
8.45%
=
19.66%
×
0.43
Jun 30, 2018
8.37%
=
19.84%
×
0.42
Mar 31, 2018
8.26%
=
21.06%
×
0.39
Dec 31, 2017
9.75%
=
22.66%
×
0.43
Sep 30, 2017
10.87%
=
27.66%
×
0.39
Jun 30, 2017
8.69%
=
21.66%
×
0.40
Mar 31, 2017
7.39%
=
18.30%
×
0.40
Dec 31, 2016
7.12%
=
17.87%
×
0.40
Sep 30, 2016
7.97%
=
19.83%
×
0.40
Jun 30, 2016
7.25%
=
19.08%
×
0.38
Mar 31, 2016
6.49%
=
17.54%
×
0.37
Dec 31, 2015
5.92%
=
17.49%
×
0.34
Sep 30, 2015
6.05%
=
19.07%
×
0.32
Jun 30, 2015
12.38%
=
26.41%
×
0.47
Mar 31, 2015
13.95%
=
30.83%
×
0.45
Dec 31, 2014
11.53%
=
26.44%
×
0.44
Sep 30, 2014
—
=
—
×
—
Jun 30, 2014
—
=
—
×
—
Mar 31, 2014
—
=
—
×
—
Based on:
10-Q (reporting date: 2019-09-30) ,
10-Q (reporting date: 2019-06-30) ,
10-Q (reporting date: 2019-03-31) ,
10-K (reporting date: 2018-12-31) ,
10-Q (reporting date: 2018-09-30) ,
10-Q (reporting date: 2018-06-30) ,
10-Q (reporting date: 2018-03-31) ,
10-K (reporting date: 2017-12-31) ,
10-Q (reporting date: 2017-09-30) ,
10-Q (reporting date: 2017-06-30) ,
10-Q (reporting date: 2017-03-31) ,
10-K (reporting date: 2016-12-31) ,
10-Q (reporting date: 2016-09-30) ,
10-Q (reporting date: 2016-06-30) ,
10-Q (reporting date: 2016-03-31) ,
10-K (reporting date: 2015-12-31) ,
10-Q (reporting date: 2015-09-30) ,
10-Q (reporting date: 2015-06-30) ,
10-Q (reporting date: 2015-03-31) ,
10-K (reporting date: 2014-12-31) ,
10-Q (reporting date: 2014-09-30) ,
10-Q (reporting date: 2014-06-30) ,
10-Q (reporting date: 2014-03-31) .
The primary reason for the increase in return on assets ratio (ROA) over Q3 2019 is the increase in profitability measured by net profit margin ratio.
Four-Component Disaggregation of ROA
Annual Data
Quarterly Data
Celgene Corp., decomposition of ROA (quarterly data)
ROA
=
Tax Burden
×
Interest Burden
×
EBIT Margin
×
Asset Turnover
Sep 30, 2019
14.22%
=
0.88
×
0.90
×
43.78%
×
0.41
Jun 30, 2019
13.45%
=
0.86
×
0.89
×
42.19%
×
0.42
Mar 31, 2019
12.61%
=
0.84
×
0.88
×
40.51%
×
0.42
Dec 31, 2018
11.40%
=
0.84
×
0.87
×
36.51%
×
0.43
Sep 30, 2018
8.45%
=
0.60
×
0.87
×
37.66%
×
0.43
Jun 30, 2018
8.37%
=
0.63
×
0.88
×
36.07%
×
0.42
Mar 31, 2018
8.26%
=
0.66
×
0.89
×
36.09%
×
0.39
Dec 31, 2017
9.75%
=
0.68
×
0.89
×
37.28%
×
0.43
Sep 30, 2017
10.87%
=
0.94
×
0.88
×
33.59%
×
0.39
Jun 30, 2017
8.69%
=
0.89
×
0.85
×
28.43%
×
0.40
Mar 31, 2017
7.39%
=
0.86
×
0.83
×
25.51%
×
0.40
Dec 31, 2016
7.12%
=
0.84
×
0.83
×
25.68%
×
0.40
Sep 30, 2016
7.97%
=
0.81
×
0.84
×
29.00%
×
0.40
Jun 30, 2016
7.25%
=
0.82
×
0.84
×
27.75%
×
0.38
Mar 31, 2016
6.49%
=
0.79
×
0.85
×
26.05%
×
0.37
Dec 31, 2015
5.92%
=
0.79
×
0.87
×
25.48%
×
0.34
Sep 30, 2015
6.05%
=
0.83
×
0.89
×
25.66%
×
0.32
Jun 30, 2015
12.38%
=
0.85
×
0.93
×
33.52%
×
0.47
Mar 31, 2015
13.95%
=
0.86
×
0.94
×
38.15%
×
0.45
Dec 31, 2014
11.53%
=
0.86
×
0.93
×
33.10%
×
0.44
Sep 30, 2014
—
=
—
×
—
×
—
×
—
Jun 30, 2014
—
=
—
×
—
×
—
×
—
Mar 31, 2014
—
=
—
×
—
×
—
×
—
Based on:
10-Q (reporting date: 2019-09-30) ,
10-Q (reporting date: 2019-06-30) ,
10-Q (reporting date: 2019-03-31) ,
10-K (reporting date: 2018-12-31) ,
10-Q (reporting date: 2018-09-30) ,
10-Q (reporting date: 2018-06-30) ,
10-Q (reporting date: 2018-03-31) ,
10-K (reporting date: 2017-12-31) ,
10-Q (reporting date: 2017-09-30) ,
10-Q (reporting date: 2017-06-30) ,
10-Q (reporting date: 2017-03-31) ,
10-K (reporting date: 2016-12-31) ,
10-Q (reporting date: 2016-09-30) ,
10-Q (reporting date: 2016-06-30) ,
10-Q (reporting date: 2016-03-31) ,
10-K (reporting date: 2015-12-31) ,
10-Q (reporting date: 2015-09-30) ,
10-Q (reporting date: 2015-06-30) ,
10-Q (reporting date: 2015-03-31) ,
10-K (reporting date: 2014-12-31) ,
10-Q (reporting date: 2014-09-30) ,
10-Q (reporting date: 2014-06-30) ,
10-Q (reporting date: 2014-03-31) .
The primary reason for the increase in return on assets ratio (ROA) over Q3 2019 is the increase in operating profitability measured by EBIT margin ratio.
Disaggregation of Net Profit Margin
Annual Data
Quarterly Data
Celgene Corp., decomposition of net profit margin ratio (quarterly data)
Net Profit Margin
=
Tax Burden
×
Interest Burden
×
EBIT Margin
Sep 30, 2019
34.64%
=
0.88
×
0.90
×
43.78%
Jun 30, 2019
32.24%
=
0.86
×
0.89
×
42.19%
Mar 31, 2019
30.11%
=
0.84
×
0.88
×
40.51%
Dec 31, 2018
26.51%
=
0.84
×
0.87
×
36.51%
Sep 30, 2018
19.66%
=
0.60
×
0.87
×
37.66%
Jun 30, 2018
19.84%
=
0.63
×
0.88
×
36.07%
Mar 31, 2018
21.06%
=
0.66
×
0.89
×
36.09%
Dec 31, 2017
22.66%
=
0.68
×
0.89
×
37.28%
Sep 30, 2017
27.66%
=
0.94
×
0.88
×
33.59%
Jun 30, 2017
21.66%
=
0.89
×
0.85
×
28.43%
Mar 31, 2017
18.30%
=
0.86
×
0.83
×
25.51%
Dec 31, 2016
17.87%
=
0.84
×
0.83
×
25.68%
Sep 30, 2016
19.83%
=
0.81
×
0.84
×
29.00%
Jun 30, 2016
19.08%
=
0.82
×
0.84
×
27.75%
Mar 31, 2016
17.54%
=
0.79
×
0.85
×
26.05%
Dec 31, 2015
17.49%
=
0.79
×
0.87
×
25.48%
Sep 30, 2015
19.07%
=
0.83
×
0.89
×
25.66%
Jun 30, 2015
26.41%
=
0.85
×
0.93
×
33.52%
Mar 31, 2015
30.83%
=
0.86
×
0.94
×
38.15%
Dec 31, 2014
26.44%
=
0.86
×
0.93
×
33.10%
Sep 30, 2014
—
=
—
×
—
×
—
Jun 30, 2014
—
=
—
×
—
×
—
Mar 31, 2014
—
=
—
×
—
×
—
Based on:
10-Q (reporting date: 2019-09-30) ,
10-Q (reporting date: 2019-06-30) ,
10-Q (reporting date: 2019-03-31) ,
10-K (reporting date: 2018-12-31) ,
10-Q (reporting date: 2018-09-30) ,
10-Q (reporting date: 2018-06-30) ,
10-Q (reporting date: 2018-03-31) ,
10-K (reporting date: 2017-12-31) ,
10-Q (reporting date: 2017-09-30) ,
10-Q (reporting date: 2017-06-30) ,
10-Q (reporting date: 2017-03-31) ,
10-K (reporting date: 2016-12-31) ,
10-Q (reporting date: 2016-09-30) ,
10-Q (reporting date: 2016-06-30) ,
10-Q (reporting date: 2016-03-31) ,
10-K (reporting date: 2015-12-31) ,
10-Q (reporting date: 2015-09-30) ,
10-Q (reporting date: 2015-06-30) ,
10-Q (reporting date: 2015-03-31) ,
10-K (reporting date: 2014-12-31) ,
10-Q (reporting date: 2014-09-30) ,
10-Q (reporting date: 2014-06-30) ,
10-Q (reporting date: 2014-03-31) .
The primary reason for the increase in net profit margin ratio over Q3 2019 is the increase in operating profitability measured by EBIT margin ratio.